Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for advance research in ConformalFLASH. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.

Ion Beam Applications SA

Varian provides software and machines for oncology, alongside patient data and care team solutions, focusing on Intelligent Cancer Care.

Varian

IBA designs, produces and markets innovative solutions for the diagnosis and treatment of cancer and other serious illnesses, and for industrial applications such as the sterilization of medical devices.

Metric
Company Name	Ion Beam Applications SA	Varian
Symbol	IBAB
MSH ID	COM:IBA-WORLDWIDE	COM:VARIAN
Market	STOCKS	PRIVATE
Sector	Healthcare	Healthcare & Health Services
Industry	Medical - Devices	Medical Technology
Country	BE	US
Stage
Employee Count	1.99K
Website	iba-worldwide.com	varian.com
LinkedIn
Founders

Metric
Market Cap	378.48M
Enterprise Value
Monthly Web Traffic		235.65K
Web Traffic Growth		0.90
Valuation
Raised Capital

Metric
Revenue	452.82M
Revenue (LTM)
Revenue (NTM)
Gross Profit	142.00M
EBITDA	18.95M
Operating Income	6.78M
Net Income	-9.62M
EPS	-0.32
Diluted EPS	-0.32
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.34
Operating Profit Margin	0.06
EBITDA Margin	0.04
Net Profit Margin	0.02
Return on Equity	0.08
Return on Assets	0.01
Return on Capital Employed	0.21

COM:IBA-WORLDWIDE

IBA

Last Close

13.76

14/02 16:35

Market Cap

358.29M

Beta: -

Volume Today

10.34K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	48.89
P/B Ratio	2.55
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.98
EV Multiple	27.29

Metric
Days Sales Outstanding
Days Payables Outstanding	102.04
Days Inventory Outstanding	281.14
Operating Cycle	398.40
Cash Conversion Cycle	306.64
Asset Turnover	0.78

Metric
Operating Cash Flow	-19.94M
Free Cash Flow	-32.95M
Cash Flow to Debt	-0.70
Operating Cash Flow/Sales	-0.04
Free Cash Flow Yield	0.05

Metric
Cash & Equivalents	115.45M
Accounts Receivable	3.92M
Inventory	137.89M
Goodwill
Debt to Capitalization	0.30
Debt to Assets	0.07
Current Ratio	1.09
Quick Ratio	0.71

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue	0.12
SG&A to Revenue	0.14